Clinical Proteomics for Patient Stratification - A GCLP Quantitative Mass Spectrometry Workflow for Multiplexed Measurement of Protein Biomarkers in FFPE Tissues (FFPE)

Home > Science Hub > Clinical Proteomics for Patient Stratification - A GCLP Quantitative Mass Spectrometry Workflow for Multiplexed Measurement of Protein Biomarkers in FFPE Tissues (FFPE)
Back to the list

July 29, 2020

Maxim Isabelle, Michael Schirm, Gwenaël Pottiez, Rudolf Guilbaud, and Lorella Di Donato

Clinical Proteomics for Patient Stratification – A GCLP Quantitative Mass Spectrometry Workflow for Multiplexed Measurement of Protein Biomarkers in FFPE Tissues (FFPE), AACR 2020

Clinical Proteomics for Patient Stratification - A GCLP Quantitative Mass Spectrometry Workflow for Multiplexed Measurement of Protein Biomarkers in FFPE Tissues (FFPE)

Download poster

You might also be interested by

CellTalk

Landmark study on metastatic breast cancer highlights the importance of identifying HER2-low patients

June 23, 2022

Proteomics/Mass Spectrometry

More info

Press Releases

CellCarta expands it proteomics portfolio with the acquisition of next-generation immuno-MRM assays from Precision Assays

May 19, 2022

Proteomics/Mass Spectrometry

More info

Brochures

High Performance Technologies for Cytokine Measurement

November 8, 2021

Immune Monitoring

More info

Brochures

Cell Therapy

November 5, 2021

Histopathology

More info